Bamboos Health Care Holdings Ltd (HK:2293)
:2293
Top Page
Bamboos Health Care Holdings Ltd
(2293)
Select Model
Select Model
Rating:64Neutral
Price Target:
HK$0.50
▲(0.00% Upside)
Action:N/ADate:07/19/25
The overall stock score of 64 for HK:2293 reflects a balanced but cautious outlook, driven primarily by mixed financial performance (score: 60, weight: 0.5) with a strong balance sheet offset by declining revenue and cash flow growth. Valuation (score: 75, weight: 0.2) provides a positive lift with an attractive P/E ratio and dividend yield, while technical analysis (score: 65, weight: 0.3) indicates short-term strength but potential overbought risks. Investors should weigh growth challenges against valuation appeal.
Positive Factors
Strong Profit Margins
High profit margins indicate efficient cost management and a strong competitive position in the healthcare staffing market, supporting long-term profitability.
Negative Factors
Declining Revenue
Consistent revenue decline raises concerns about the company's ability to sustain growth and maintain its market position, potentially impacting long-term financial health.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Profit Margins
High profit margins indicate efficient cost management and a strong competitive position in the healthcare staffing market, supporting long-term profitability.
Read all positive factors
Bamboos Health Care Holdings Ltd (2293) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$160.98M
Dividend Yield8%
Average Volume (3M)19.31K
Price to Earnings (P/E)5.3
Beta (1Y)0.06
Revenue Growth-21.50%
EPS Growth-43.25%
CountryHK
Employees75
SectorIndustrials
Sector Strength72
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.02
Shares Outstanding402,460,000
10 Day Avg. Volume2,658
30 Day Avg. Volume19,312
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)0.87
Price to Sales (P/S)2.69
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bamboos Health Care Holdings Ltd Business Overview & Revenue Model
Company Description
Bamboos Health Care Holdings Limited, an investment holding company, provides healthcare staffing solutions in Hong Kong. It offers healthcare institution support and private nursing solutions. The company also provides marketing and consulting se...
How the Company Makes Money
Bamboos Health Care Holdings Ltd generates revenue through its staffing services by charging fees for the placement of healthcare professionals. The company earns money by contracting with healthcare facilities that require temporary or permanent ...
Bamboos Health Care Holdings Ltd Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
75
Positive
Cash Flow
60
Neutral
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 74.40M | 94.79M | 126.56M | 140.29M | 109.67M |
| Gross Profit | 31.00M | 84.72M | 115.12M | 91.33M | 82.19M |
| EBITDA | 34.98M | 52.76M | 69.85M | 81.32M | 78.05M |
| Net Income | 17.54M | 30.92M | 46.92M | 58.62M | 61.02M |
Balance Sheet | |||||
| Total Assets | 315.90M | 318.06M | 346.83M | 351.35M | 240.84M |
| Cash, Cash Equivalents and Short-Term Investments | 52.96M | 81.15M | 93.27M | 86.27M | 98.31M |
| Total Debt | 62.13M | 63.73M | 68.24M | 68.96M | 3.31M |
| Total Liabilities | 86.54M | 99.74M | 124.51M | 140.75M | 46.05M |
| Stockholders Equity | 229.36M | 218.33M | 222.32M | 210.60M | 194.79M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 35.75M | 41.67M | 100.37M | 49.42M |
| Operating Cash Flow | 0.00 | 37.41M | 41.94M | 116.11M | 49.44M |
| Investing Cash Flow | 0.00 | -7.09M | 6.92M | -111.63M | -71.38M |
| Financing Cash Flow | 0.00 | -42.44M | -41.80M | 25.15M | -23.04M |
Bamboos Health Care Holdings Ltd Technical Analysis
Negative
0.50
Price Trends
0.47
Negative
0.49
Negative
0.51
Negative
Market Momentum
-0.02
Positive
25.68
Positive
-2.56
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2293, the sentiment is Negative. The current price of 0.5 is above the 20-day moving average (MA) of 0.45, above the 50-day MA of 0.47, and below the 200-day MA of 0.51, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 25.68 is Positive, neither overbought nor oversold. The STOCH value of -2.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2293.
Bamboos Health Care Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$356.42M | 4.98 | 4.28% | 7.10% | -2.88% | -22.83% | |
64 Neutral | HK$160.98M | 5.31 | 6.92% | 8.00% | -21.50% | -43.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | HK$56.73M | 362.73 | -19.93% | ― | -2.91% | 55.41% | |
52 Neutral | HK$311.23M | 4.11 | 3.54% | 3.75% | 9.07% | 8.95% | |
43 Neutral | HK$84.86M | -4.87 | -27.01% | ― | -11.68% | -71.01% | |
42 Neutral | HK$124.00M | -20.58 | -573.79% | ― | -30.45% | -734.38% |
* Industrials Sector Average
HK:2293
Bamboos Health Care Holdings Ltd
0.40
-0.15
-27.27%
HK:8143
Good Fellow Healthcare Holdings Limited
0.11
0.06
100.00%
HK:1419
Human Health Holdings Ltd.
0.82
0.10
13.89%
HK:0722
UMP Healthcare Holdings Limited
0.45
0.08
20.92%
HK:8307
Medicskin Holdings Ltd.
0.14
>-0.01
-4.67%
HK:8357
Republic Healthcare Limited
0.14
0.07
91.55%
Bamboos Health Care Holdings Ltd Corporate Events
Bamboos Health Care Secures Unanimous Shareholder Approval at AGM
Nov 28, 2025
Bamboos Health Care Holdings Ltd announced that all resolutions proposed at their Annual General Meeting on November 28, 2025, were unanimously approved by shareholders. Key resolutions included the re-election of directors, approval of financial ...
Bamboos Health Care Clarifies Dividend Typographical Error
Oct 24, 2025
Bamboos Health Care Holdings Ltd issued a clarification announcement regarding a typographical error in their annual report and circular for the year ended 30 June 2025. The proposed final dividend was incorrectly stated as HK2.5 cents per share i...
Bamboos Health Care Holdings Ltd Announces Annual General Meeting and Strategic Resolutions
Oct 24, 2025
Bamboos Health Care Holdings Ltd has announced its upcoming annual general meeting scheduled for November 28, 2025, in Hong Kong. Key agenda items include the approval of financial statements, re-election of directors, auditor appointment, and a f...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.